Brian MacDonald
Plus aucun poste en cours
Fortune : 528 398 $ au 31/05/2024
Historique de carrière de Brian MacDonald
Anciens postes connus de Brian MacDonald
Sociétés | Poste | Début | Fin |
---|---|---|---|
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | - | - |
Directeur Général | - | 25/02/2020 | |
Directeur Technique/Scientifique/R&D | 01/10/2021 | 20/12/2023 | |
Fondateur | - | 20/12/2023 | |
DISC MEDICINE, INC. | Directeur Technique/Scientifique/R&D | - | 20/12/2023 |
Statistiques
Internationale
Etats-Unis | 3 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 2 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sectorielle
Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
DISC MEDICINE, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Brian MacDonald
- Expérience